DNA
$9.89
Revenue | $38.84Mn |
Net Profits | $-80.76Mn |
Net Profit Margins | -207.93% |
Ginkgo Bioworks Holdings Inc’s revenue fell -56.39% since last year same period to $38.84Mn in the Q3 2025. On a quarterly growth basis, Ginkgo Bioworks Holdings Inc has generated -21.71% fall in its revenue since last 3-months.
Ginkgo Bioworks Holdings Inc’s net profit fell -43.18% since last year same period to $-80.76Mn in the Q3 2025. On a quarterly growth basis, Ginkgo Bioworks Holdings Inc has generated -33.92% fall in its net profits since last 3-months.
Ginkgo Bioworks Holdings Inc’s net profit margin fell -228.27% since last year same period to -207.93% in the Q3 2025. On a quarterly growth basis, Ginkgo Bioworks Holdings Inc has generated -71.05% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.1 |
EPS Estimate Current Year | -0.1 |
Ginkgo Bioworks Holdings Inc’s earning per share (EPS) estimates for the current quarter stand at -0.1 - a -25% fall from last quarter’s estimates.
Ginkgo Bioworks Holdings Inc’s earning per share (EPS) estimates for the current year stand at -0.1.
Earning Per Share (EPS) | -1.1 |
Ginkgo Bioworks Holdings Inc’s earning per share (EPS) fell -900% since last year same period to -1.1 in the Q2 2025. This indicates that the Ginkgo Bioworks Holdings Inc has generated -900% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-08-07 | -0.1 | -1.1 | -1000% |
2025-05-06 | -0.08 | -1.68 | -2000% |